gyki 52466 and aniracetam
gyki 52466 has been researched along with aniracetam in 7 studies
Research
Studies (7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chaudhary, A; Johansen, TH; Verdoorn, TA | 1 |
| Camici, O; Corazzi, L; Fallarino, F; Fioretti, MC; Genazzani, AA; L'Episcopo, MR; Nicoletti, F; Silla, S | 1 |
| al-Zubaidy, Z; Chapman, AG; Meldrum, BS | 1 |
| Chapman, AG; Chimirri, A; De Sarro, A; de Sarro, G; Gitto, R; Giusti, P; Grasso, S | 1 |
| Lu, Y; Wehner, JM | 1 |
| Croucher, MJ; Patel, DR; Young, AM | 1 |
| Dubiela, FP; Hipolide, DC; Moreira, KD; Nobrega, JN; Queiroz, CM; Sita, LV; Tufik, S | 1 |
Other Studies
7 other study(ies) available for gyki 52466 and aniracetam
| Article | Year |
|---|---|
Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Benzothiadiazines; Excitatory Amino Acid Antagonists; Humans; Pyrrolidinones; Receptors, AMPA; Receptors, Kainic Acid; Recombinant Proteins; Xenopus laevis | 1995 |
[3H]aniracetam binds to specific recognition sites in brain membranes.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Benzothiadiazines; Binding Sites; Brain; Cells, Cultured; Cerebellum; Glutamic Acid; Male; Membranes; Phorbol 12,13-Dibutyrate; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tritium | 1995 |
Aniracetam reverses the anticonvulsant action of NBQX and GYKI 52466 in DBA/2 mice.
Topics: Acoustic Stimulation; Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Dose-Response Relationship, Drug; Mice; Mice, Inbred DBA; Piperazines; Pyrrolidinones; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Seizures | 1993 |
GYKI 52466 and related 2,3-benzodiazepines as anticonvulsant agents in DBA/2 mice.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Flumazenil; Male; Mice; Mice, Inbred DBA; Pyrrolidinones; Rats; Rats, Sprague-Dawley | 1995 |
Enhancement of contextual fear-conditioning by putative (+/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor modulators and N-methyl-D-aspartate (NMDA) receptor antagonists in DBA/2J mice.
Topics: Acoustic Stimulation; Animals; Anti-Anxiety Agents; Benzodiazepines; Conditioning, Classical; Cues; Excitatory Amino Acid Antagonists; Fear; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Nootropic Agents; Pyrrolidines; Pyrrolidinones; Quinoxalines; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 1997 |
Presynaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor-mediated stimulation of glutamate and GABA release in the rat striatum in vivo: a dual-label microdialysis study.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anti-Anxiety Agents; Antihypertensive Agents; Benzodiazepines; Benzothiadiazines; Calcium; Carbon Radioisotopes; Corpus Striatum; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Kynurenic Acid; Male; Microdialysis; Nootropic Agents; Potassium; Presynaptic Terminals; Pyrrolidinones; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Tritium | 2001 |
AMPA receptors mediate passive avoidance deficits induced by sleep deprivation.
Topics: Analysis of Variance; Animals; Avoidance Learning; Benzodiazepines; Excitatory Amino Acid Antagonists; Gene Expression Regulation; Learning Disabilities; Male; Nootropic Agents; Protein Binding; Pyrrolidinones; Rats; Rats, Wistar; Receptors, AMPA; Sleep Deprivation; Time Factors; Tritium | 2013 |